GlassScriptPhysician profile
Jason C Rosenberg
NPI 1407969777
$81,919.05
in general payments reported to CMS, 2019-2025
39 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $12K · 2021: $5,708 · 2022: $19K · 2023: $19K · 2024: $6,090 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Food and Beverage: $7,766 · Travel and Lodging: $3,916 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,500.00 |
| Food and Beverage | $7,765.93 |
| Travel and Lodging | $3,916.49 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $31,858.35 | 2019-2024 | Mild Device Kit |
| Eminent Spine, LLC | $16,107.59 | 2023-2025 | Eminent Spine Si Screw System |
| Boston Scientific Corporation | $11,305.82 | 2020-2024 | Intracept |
| Omnia Medical, LLC | $5,500.00 | 2025 | |
| Spinal Simplicity, LLC | $3,991.67 | 2022-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $3,768.27 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Biotronik Nro, INC. | $3,357.15 | 2024-2025 | Prospera |
| Stryker Corporation | $1,094.80 | 2019-2025 | Spinejack, Mild Device Kit |
| Spr Therapeutics, INC | $566.43 | 2021-2025 | Sprint Pns System |
| Nalu Medical, INC. | $363.70 | 2021 | |
| Medtronic, INC. | $343.18 | 2024-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Si-Bone, INC. | $313.67 | 2023-2025 | |
| Painteq LLC | $305.03 | 2022-2023 | Painteq |
| Globus Medical, INC. | $299.73 | 2025 | Vyrsa V1, Senza |
| Nevro Corp. | $298.69 | 2019-2024 | Senza |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $290.87 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $271.25 | 2023 | Intracept |
| Mml US, INC. | $229.53 | 2025 | Reactiv8 |
| Foundation Medicine, INC. | $165.02 | 2021 | |
| Vertiflex, INC. | $154.53 | 2019 | |
| Abbvie INC. | $151.97 | 2021-2023 | Botox |
| Grt US Holding, INC. | $130.85 | 2022 | |
| Nuvasive, INC. | $122.04 | 2019 | |
| Lenoss Medical INC | $117.11 | 2025 | Osteopearl |
| Alexion Pharmaceuticals, INC. | $96.78 | 2025 | Strensiq |
| Peerless Surgical INC. | $94.83 | 2024 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Averitas Pharma INC. | $89.14 | 2024 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $81.82 | 2020 | |
| Merz Pharmaceuticals, LLC | $79.45 | 2022 | |
| Alevio, LLC | $72.33 | 2020 | |
| Collegium Pharmaceutical, INC. | $63.28 | 2025 | Belbuca |
| Allergan, INC. | $48.92 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $23.03 | 2021 | |
| Depuy Synthes Sales INC. | $20.13 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.40 | 2022 | |
| Lilly USA, LLC | $15.65 | 2020 | |
| Baudax Bio INC. | $15.54 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.